One of the many innovations we offer to patients battling cancer is immunotherapy. This treatment uses certain parts of a person's immune system to fight cancer. The treatment stimulates your body's own immune system to work harder or smarter to attack cancer cells. We use immunotherapy agents including Keytruda, Opdivo, and Provenge, and many others.
We Boost the Killing Power of the Body's Immune System
We administer these agents intravenously. Patients tolerate them well, with little or no side effects reported. Our goal is to boost the "killing power" of the body's immune system and teach the body's immune system to differentiate between healthy cells and cancer cells. Therefore, immunotherapy works against cancer in a variety of ways.
Individual Patient Needs Determine Our Approach
Immunotherapies used to stop, control, or suppress cancer can be used by themselves for some types of cancers. For others, immunotherapy seems to work better when used in conjunction with a variety of treatment types. We work with each and every patient to evaluate their individual needs and identify a clear and personalized path to treatment.
Our Clinical Research Identifies New Immunotherapies
In our Clinical Research Department, newer types of immunotherapies are already being offered to our existing patients. Immunotherapy studies are currently being conducted at our sites for diseases such as Lung, Colorectal, Breast, Pancreatic, and Prostate cancers.
